GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SK Biopharmaceuticals Co Ltd (XKRX:326030) » Definitions » Purchase Of Investment

SK Biopharmaceuticals Co (XKRX:326030) Purchase Of Investment : ₩-77,279 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is SK Biopharmaceuticals Co Purchase Of Investment?

SK Biopharmaceuticals Co's purchase of investment for the three months ended in Mar. 2024 was ₩-1,433 Mil. It means SK Biopharmaceuticals Co spent ₩1,433 Mil on purchasing investments. SK Biopharmaceuticals Co's purchase of investment for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-77,279 Mil.

Compared with last quarter (₩0 Mil in Dec. 2023 ), SK Biopharmaceuticals Co spent more money on purchasing investments in Mar. 2024 (₩-1,433 Mil).


SK Biopharmaceuticals Co Purchase Of Investment Historical Data

The historical data trend for SK Biopharmaceuticals Co's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SK Biopharmaceuticals Co Purchase Of Investment Chart

SK Biopharmaceuticals Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only -29,012.28 -313,161.94 -174,036.00 -458,344.15 -106,412.83

SK Biopharmaceuticals Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -30,567.55 -15,845.28 -60,000.00 - -1,433.23

SK Biopharmaceuticals Co Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-77,279 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SK Biopharmaceuticals Co Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of SK Biopharmaceuticals Co's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


SK Biopharmaceuticals Co (XKRX:326030) Business Description

Traded in Other Exchanges
N/A
Address
221, Pangyoyeok-ro, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13494
SK Biopharmaceuticals Co Ltd is a pharmaceutical company engaged in research and development of new drugs for treatment of central nervous system (CNS) disorders. The company is also researching for the development of drugs to treat brain tumors, including metastatic tumors. It has a Bio Science Research Institute in Pangyo Techno Valley in Gyeonggi Province. Its drugs in pipeline include Cenobamate, Solriamfetol, Carisbamate, Relenopride, SKL13865, SKL20540, SKL-PSY, and SKL24741.

SK Biopharmaceuticals Co (XKRX:326030) Headlines

No Headlines